Compounds > 3-iodobenzylguanidine
Page last updated: 2024-08-24

3-iodobenzylguanidine and Headache

3-iodobenzylguanidine has been researched along with Headache in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Eguchi, S; Hasegawa, D; Hasegawa, T; Ichihashi, Y; Kanomata, N; Narumi, S; Nozaki, T; Ono, R; Ozawa, M; Sato, T; Umehara, N; Yada, K1
Adamsbaum, C; Bougnères, PF; Coutant, R; Dubousset, J; Guinebretière, JM; Oberlin, O; Pein, F; Teinturier, C1

Reviews

1 review(s) available for 3-iodobenzylguanidine and Headache

ArticleYear
Prognosis of children with malignant pheochromocytoma. Report of 2 cases and review of the literature.
    Hormone research, 1999, Volume: 52, Issue:3

    Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Catecholamines; Child; Fatal Outcome; Female; Headache; Humans; Hypertension; Iodine Radioisotopes; Male; Neoplasm Metastasis; Pheochromocytoma; Prognosis; Sacroiliac Joint; Sacrum; Spinal Neoplasms

1999

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Headache

ArticleYear
Hereditary paraganglioma presenting with atypical symptoms: Case report.
    Medicine, 2021, Nov-19, Volume: 100, Issue:46

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Catecholamines; Child; Headache; Humans; Male; Paraganglioma; Pheochromocytoma; Polyuria; Posterior Leukoencephalopathy Syndrome; Proteinuria; Radionuclide Imaging; Weight Loss

2021